rs151312678
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001127217.3(SMAD9):c.48C>T(p.Pro16Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000602 in 1,614,188 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001127217.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001127217.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMAD9 | NM_001127217.3 | MANE Select | c.48C>T | p.Pro16Pro | synonymous | Exon 2 of 7 | NP_001120689.1 | ||
| SMAD9 | NM_001378621.1 | c.48C>T | p.Pro16Pro | synonymous | Exon 2 of 6 | NP_001365550.1 | |||
| SMAD9 | NM_005905.6 | c.48C>T | p.Pro16Pro | synonymous | Exon 2 of 6 | NP_005896.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMAD9 | ENST00000379826.5 | TSL:5 MANE Select | c.48C>T | p.Pro16Pro | synonymous | Exon 2 of 7 | ENSP00000369154.4 | ||
| SMAD9 | ENST00000350148.10 | TSL:1 | c.48C>T | p.Pro16Pro | synonymous | Exon 2 of 6 | ENSP00000239885.6 | ||
| SMAD9 | ENST00000399275.7 | TSL:1 | n.48C>T | non_coding_transcript_exon | Exon 1 of 6 | ENSP00000382216.3 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152182Hom.: 3 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00101 AC: 254AN: 251308 AF XY: 0.00112 show subpopulations
GnomAD4 exome AF: 0.000606 AC: 886AN: 1461888Hom.: 8 Cov.: 32 AF XY: 0.000668 AC XY: 486AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000565 AC: 86AN: 152300Hom.: 3 Cov.: 33 AF XY: 0.000551 AC XY: 41AN XY: 74472 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
p.Pro16Pro in exon 2 of SMAD9: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.3% (55/16502) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs151312678).
SMAD9-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Pulmonary hypertension, primary, 2 Benign:1
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at